For every drug that reaches the market, pharmaceutical companies invest time and effort in dozens, if not hundreds, of drugs that ultimately fail. Dutch biotechnology company MIMETAS, led by CEOs Jos Joore and Paul Vulto, is on a mission to change the way medicines are developed.
